Rezolute (RZLT) Interest & Investment Income (2012 - 2026)
Rezolute (RZLT) reported Interest & Investment Income of -$162000.0 for Q1 2026, down 671.43% on a YoY basis from $28350.0 in Q1 2025, and down 111.2% sequentially from $1.4 million in Q4 2025.
Rezolute (RZLT) Interest & Investment Income (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 15 years of Interest & Investment Income data on file, last reported at -$162000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 671.43% year-over-year to -$162000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (down 55.69% YoY), and the FY2025 full-year result was $5.5 million, up 12.57% from the prior year.
- Interest & Investment Income retreated to -$162000.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.6 million in Q2 2024 to a low of -$162000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $624500.0 in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 6600.0% in 2022 and slumped 671.43% in 2026, its largest moves.
- Tracing RZLT's Interest & Investment Income over 5 years: stood at $849000.0 in 2022, then soared by 53.47% to $1.3 million in 2023, then advanced by 3.15% to $1.3 million in 2024, then gained by 7.66% to $1.4 million in 2025, then sank by 111.2% to -$162000.0 in 2026.
- Business Quant data shows RZLT's Interest & Investment Income at -$162000.0 in Q1 2026, $1.4 million in Q4 2025, and $56000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | -162,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162,000.00 |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 4.34 Mn |
| Mar 31, 2023 | -132,000.00 |
| Dec 31, 2022 | 849,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 55,000.00 |